These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 14257064)

  • 1. ENHANCEMENT OF FIBRINOLYSIS AND ANTAGONISM OF ANTIPLASMIN BY REVERSIBLE PLASMIN INHIBITORS.
    MAXWELL RE; LEWANDOWSKI V; NICKEL VS
    Life Sci (1962); 1965 Jan; 4():45-51. PubMed ID: 14257064
    [No Abstract]   [Full Text] [Related]  

  • 2. [NEUTRALIZATION OF ANTIPLASMIN IN THE BLOOD DURING PROTECTIVE REACTIONS OF THE PHYSIOLOGIC ANTICOAGULATION SYSTEM].
    KUDRIASHOV BA; ANDREENKO GV; KALISHEVSKAIA TM
    Probl Gematol Pereliv Krovi; 1964 Apr; 9():12-5. PubMed ID: 14195816
    [No Abstract]   [Full Text] [Related]  

  • 3. ON THE INTERACTION OF FIBRINOLYSIN (PLASMIN) WITH THE INHIBITORS ANTIFIBRINOLYSIN AND SOYBEAN TRYPSIN INHIBITOR.
    NANNINGA LB; GUEST MM
    Arch Biochem Biophys; 1964 Dec; 108():542-51. PubMed ID: 14244698
    [No Abstract]   [Full Text] [Related]  

  • 4. [ON THE DEFENSIVE REFLEX ANTIPLASMIN SYSTEM IN THE BODY].
    KUDRIASHOV BA; KALISHEVSKAIA TM
    Biull Eksp Biol Med; 1963 Sep; 56():29-33. PubMed ID: 14124776
    [No Abstract]   [Full Text] [Related]  

  • 5. [Research on the inhibitors of fibrinolysis: the methods of measuring antistreptokinase, antiplasmin and antitrypsin].
    GIACOMAZZI G
    Haematol Lat; 1961; 4():255-71. PubMed ID: 13898268
    [No Abstract]   [Full Text] [Related]  

  • 6. INACTIVATION OF ANTIPLASMIN AND COMPLEMENT C1 IN HUMAN PLASMA RENDERED FIBRINOLYTIC BY SYNTHETIC ORGANIC COMPOUNDS.
    VONKAULLA KN
    Thromb Diath Haemorrh; 1963 Nov; 10():151-63. PubMed ID: 14081277
    [No Abstract]   [Full Text] [Related]  

  • 7. [STUDIES ON TRYPSIN INHIBITOR AND ANTIPLASMIN IN HUMAN SERUM. I. ON NORMAL AND ARTERIOSCLEROTIC CASES].
    MATSUDA T
    Nihon Ketsueki Gakkai Zasshi; 1963 Oct; 26():581-9. PubMed ID: 14095688
    [No Abstract]   [Full Text] [Related]  

  • 8. Observations on fibrinolysis; plasminogen, plasmin, and antiplasmin content of human blood.
    MACFARLANE RG; PILLING J
    Lancet; 1946 Oct; 2(6425):562-5. PubMed ID: 21001709
    [No Abstract]   [Full Text] [Related]  

  • 9. [Molecular markers of hemostatic-mechanisms--plasmin-alpha 2 plasmin inhibitor complex].
    Kawai Y; Watanabe K
    Rinsho Byori; 1989 Mar; 37(3):248-55. PubMed ID: 2526263
    [No Abstract]   [Full Text] [Related]  

  • 10. AN ACTIVE STEREO-ISOMER (TRANS-FORM) OF AMCHA AND ITS ANTIFIBRINOLYTIC (ANTIPLASMINIC) ACTION IN VITRO AND IN VIVO.
    OKAMOTO S; SATO S; TAKADA Y; OKAMOTO U
    Keio J Med; 1964 Dec; 13():177-85. PubMed ID: 14279228
    [No Abstract]   [Full Text] [Related]  

  • 11. [ANTIPLASMIN ACTIVITY OF THE PANCREATIC TRYPSIN INHIBITOR AND OF EPSILON-AMINOCAPROIC ACID].
    DEBARBIERI A; SCEVOLA ME; FRANCHINI M
    Boll Chim Farm; 1964 Jan; 103():37-40. PubMed ID: 14131376
    [No Abstract]   [Full Text] [Related]  

  • 12. [STUDY OF THE ANTIFIBRINOLYTIC PROPERTIES OF KUNITZ'S PANCREATIC INHIBITOR. (TESTS IN VITRO AND IN VIVO)].
    GIBELLI A; SCARDI F
    Gazz Int Med Chir; 1963 Oct; 67():2105-16. PubMed ID: 14095279
    [No Abstract]   [Full Text] [Related]  

  • 13. [ON THE EFFECT OF BLOOD COAGULATION INHIBITORS AND FIBRINOLYSIS ON THE SANARELLI-SHWARTZMAN PHENOMENON].
    HAUSTEIN KO; MARKWARDT F
    Thromb Diath Haemorrh; 1965 Mar; 13():60-4. PubMed ID: 14285979
    [No Abstract]   [Full Text] [Related]  

  • 14. [RELATION OF ANTIPLASMIN AND ANTITRYPSIN IN THE BLOOD PLASMA].
    MAKI M
    Nihon Sanka Fujinka Gakkai Zasshi; 1963 Oct; 15():1143-6. PubMed ID: 14092838
    [No Abstract]   [Full Text] [Related]  

  • 15. [Changes in coagulation and fibrinolysis cascades upon extracorporeal circulation].
    Kanamori N; Koiwa F; Uda S
    Nihon Rinsho; 1991 Dec; 49 Suppl():81-6. PubMed ID: 1839690
    [No Abstract]   [Full Text] [Related]  

  • 16. Carbon monoxide and nitric oxide modulate α₂-antiplasmin and plasmin activity: role of heme.
    Arkebauer MR; Kanaparthy SS; Malayaman SN; Vosseller K; Nielsen VG
    Blood Coagul Fibrinolysis; 2011 Dec; 22(8):712-9. PubMed ID: 22024794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [STUDIES ON TRYPSIN INHIBITOR AND ANTIPLASMIN IN HUMAN SERUM. II. ON VARIOUS DISEASES EXCEPT ARTERIOSCLEROSIS].
    MATSUDA T
    Nihon Ketsueki Gakkai Zasshi; 1963 Oct; 26():590-7. PubMed ID: 14098708
    [No Abstract]   [Full Text] [Related]  

  • 18. Alpha2-antiplasmin and its deficiency: fibrinolysis out of balance.
    Carpenter SL; Mathew P
    Haemophilia; 2008 Nov; 14(6):1250-4. PubMed ID: 19141165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An enzyme-linked immunosorbent assay (ELISA) for the measurement of plasmin-alpha 2-antiplasmin complex in human plasma--application to the detection of in vivo activation of the fibrinolytic system.
    Holvoet P; de Boer A; Verstreken M; Collen D
    Thromb Haemost; 1986 Oct; 56(2):124-7. PubMed ID: 2433784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasmin-alpha 2-plasmin inhibitor complex in plasma of patients with disseminated intravascular coagulation.
    Takahashi H; Hanano M; Takizawa S; Tatewaki W; Shibata A
    Am J Hematol; 1988 Jul; 28(3):162-6. PubMed ID: 2457307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.